bio sketch column
Marshall Morningstar, PhD, is the director of Medicinal Chemistry at the Broad Institute Center for the Science of Therapeutics. Marshall obtained a BS in chemistry at University of California, Berkeley, and a PhD in synthetic organic chemistry at Massachusetts Institute of Technology (1994). Following a postdoctoral position at the National Cancer Institute and a short period as a medicinal chemist at Tanabe Research Laboratories, he joined AstraZeneca as a project leader working in Infection research at the Waltham location for 11 years. In 2012, he took on the role as Head of Chemistry for Collaborative Discovery efforts for metabolic, pain and oncology research for GVK BIO working out of Hyderabad, India. Starting in 2015, he joined the Broad Institute where he oversees a portfolio of neglected disease programs.